Fumihito Toshima

891 total citations · 1 hit paper
22 papers, 524 citations indexed

About

Fumihito Toshima is a scholar working on Surgery, Oncology and Epidemiology. According to data from OpenAlex, Fumihito Toshima has authored 22 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 9 papers in Oncology and 7 papers in Epidemiology. Recurrent topics in Fumihito Toshima's work include Neuroendocrine Tumor Research Advances (7 papers), Pancreatic and Hepatic Oncology Research (6 papers) and IgG4-Related and Inflammatory Diseases (4 papers). Fumihito Toshima is often cited by papers focused on Neuroendocrine Tumor Research Advances (7 papers), Pancreatic and Hepatic Oncology Research (6 papers) and IgG4-Related and Inflammatory Diseases (4 papers). Fumihito Toshima collaborates with scholars based in Japan. Fumihito Toshima's co-authors include Osamu Matsui, Norihide Yoneda, Toshifumi Gabata, Kotaro Yoshida, Dai Inoue, Tetsuya Minami, Yoh Zen, Takashi Matsubara, Kenichiro Okumura and Kumi Ozaki and has published in prestigious journals such as Radiology, American Journal of Roentgenology and Medicine.

In The Last Decade

Fumihito Toshima

19 papers receiving 513 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IgG4-Related Disease

2015 306 citations Dai Inoue, Kotaro Yoshida et al. Medicine profile →

Peers

Countries citing papers authored by Fumihito Toshima

Since Specialization

Citations

This map shows the geographic impact of Fumihito Toshima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumihito Toshima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumihito Toshima more than expected).

Fields of papers citing papers by Fumihito Toshima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumihito Toshima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumihito Toshima. The network helps show where Fumihito Toshima may publish in the future.

Co-authorship network of co-authors of Fumihito Toshima

This figure shows the co-authorship network connecting the top 25 collaborators of Fumihito Toshima. A scholar is included among the top collaborators of Fumihito Toshima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumihito Toshima. Fumihito Toshima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Case of simultaneous occurrence of hepatitis, cholangitis, and pancreatitis as immune-related adverse events induced by immune checkpoint inhibitor therapy: a case report 2025 ·Abdominal Radiology ·(unknown), Dai Inoue, Takahiro Komori, Takashi Matsubara, Fumihito Toshima, Kazuto Kozaka, (unknown), Hiroko Ikeda, Satoshi Kobayashi	1
2	Case Report: Medullary carcinoma of the pancreas with MLH1 promoter hypermethylation, induced deficient mismatch repair, successfully treated with an immune checkpoint inhibitor 2025 ·Frontiers in Oncology ·Koushiro Ohtsubo, Shigeki Sato, (unknown), Hiroshi Kotani, Akihiro Nishiyama, Kaname Yamashita, (unknown), Fumihito Toshima, (unknown), Toshifumi Gabata, Hiroko Ikeda, Atsushi Watanabe, Kenji Notohara, Takao Fujisawa, Yoshiaki Nakamura, Takayuki Yoshino, Kunio Miyake, Kazuhiro Miwa, Shinji Takeuchi	0
3	Transthyretin amyloid cardiomyopathy disease burden quantified using 99mTc-pyrophosphate SPECT/CT: volumetric parameters versus SUVmax ratio at 1 and 3 hours 2023 ·Journal of Nuclear Cardiology ·Satoru Watanabe, Kenichi Nakajima, Fumihito Toshima, Hiroshi Wakabayashi, Shohei Yoshida, (unknown), Junji Komatsu, Takahiro Konishi, Seigo Kinuya	3
4	Computer-Aided Detection of Subsolid Nodules on Chest Computed Tomography: Assessment of Visualization on Vessel-Suppressed Images 2023 ·Journal of Computer Assisted Tomography ·Kotaro Yoshida, (unknown), Fumihito Toshima, Kazuto Kozaka, (unknown), Takeshi Kobayashi, Toshifumi Gabata	0
5	Predicting axillary lymph node metastasis in breast cancer using the similarity of quantitative dual-energy CT parameters between the primary lesion and axillary lymph node 2022 ·Japanese Journal of Radiology ·(unknown), Hiroko Kawashima, Norihide Yoneda, Fumihito Toshima, Miki Hirata, Satoshi Kobayashi, (unknown)	13
6	Single-Center Analysis of Pegfilgrastim-induced Aortitis Using a Drug Prescription Database and CT Findings 2022 ·Radiology ·(unknown), Kotaro Yoshida, Fumihito Toshima, Kazuto Kozaka, (unknown), Yoshimichi Sai, Toshifumi Gabata	7
7	DECT Numbers in Upper Abdominal Organs for Differential Diagnosis: A Feasibility Study 2022 ·Tomography ·Fumihito Toshima, Norihide Yoneda, (unknown), Dai Inoue, (unknown)	1
8	CT-diagnosed extra-pancreatic extension of pancreatic ductal adenocarcinoma is a more reliable prognostic factor for survival than pathology-diagnosed extension 2021 ·European Radiology ·Fumihito Toshima, Dai Inoue, Kotaro Yoshida, (unknown), Norihide Yoneda, (unknown), Toshifumi Gabata	8
9	CT Findings of Thoracic Paravertebral Lesions in IgG4-Related Disease 2019 ·American Journal of Roentgenology ·Dai Inoue, Yoh Zen, Takahiro Komori, Kotaro Yoshida, Norihide Yoneda, Azusa Kitao, Kazuto Kozaka, (unknown), Junichi Matsumoto, Fumihito Toshima, Satoshi Kobayashi, Toshifumi Gabata	16
10	CT imaging comparison between intraductal papillary neoplasms of the bile duct and papillary cholangiocarcinomas 2018 ·European Radiology ·Takahiro Komori, Dai Inoue, Yoh Zen, Norihide Yoneda, Azusa Kitao, Kazuto Kozaka, (unknown), Fumihito Toshima, Takashi Matsubara, Satoshi Kobayashi, Toshifumi Gabata	14
11	Is the combination of MR and CT findings useful in determining the tumor grade of pancreatic neuroendocrine tumors? 2017 ·Japanese Journal of Radiology ·Fumihito Toshima, Dai Inoue, Takahiro Komori, Kotaro Yoshida, Norihide Yoneda, Tetsuya Minami, Osamu Matsui, Hiroko Ikeda, Toshifumi Gabata	28
12	Imaging and pathological features of gastric lesion of immunoglobulin G4-related disease: A case report and review of the recent literature 2016 ·Modern Rheumatology ·Dai Inoue, Norihide Yoneda, Kotaro Yoshida, (unknown), Jun Kinoshita, Sachio Fushida, Fumihito Toshima, Tetsuya Minami, Masayuki Takahira, (unknown), Hiroko Ikeda, Toshifumi Gabata, Mitsuhiro Kawano	11
13	Adenosquamous carcinoma of pancreas: CT and MR imaging features in eight patients, with pathologic correlations and comparison with adenocarcinoma of pancreas 2016 ·Abdominal Radiology ·Fumihito Toshima, Dai Inoue, Kotaro Yoshida, Norihide Yoneda, Tetsuya Minami, Satoshi Kobayashi, (unknown), Osamu Matsui, Toshifumi Gabata	32
14	Dynamic CT findings of cholangiolocellular carcinoma: correlation with angiography-assisted CT and histopathology 2016 ·Abdominal Radiology ·Kazuto Kozaka, Osamu Matsui, Satoshi Kobayashi, Wataru Koda, Tetsuya Minami, Azusa Kitao, Dai Inoue, Norihide Yoneda, Kotaro Yoshida, Fumihito Toshima, Yasuni Nakanuma, Toshifumi Gabata	10
15	IgG4-Related Disease breakdown → 2015 ·Medicine ·Dai Inoue, Kotaro Yoshida, Norihide Yoneda, Kumi Ozaki, Takashi Matsubara, Kei-ichi Nagai, Kenichiro Okumura, Fumihito Toshima, (unknown), Tetsuya Minami, Osamu Matsui, Toshifumi Gabata, Yoh Zen	306
16	Comparison of local control effects of superselective transcatheter arterial chemoembolization using epirubicin plus mitomycin C and miriplatin for hepatocellular carcinoma 2012 ·Japanese Journal of Radiology ·Shiro Miyayama, Masashi Yamashiro, Yoshihiro Shibata, (unknown), Miki Yoshida, (unknown), Fumihito Toshima, Osamu Matsui	41
17	Variations in feeding arteries of hepatocellular carcinoma located in the left hepatic lobe 2012 ·Japanese Journal of Radiology ·Shiro Miyayama, Masashi Yamashiro, Yoshihiro Shibata, Masahiro Hashimoto, Miki Yoshida, (unknown), Fumihito Toshima, Osamu Matsui	11
18	Origins of Feeding Arteries of Hepatocellular Carcinoma Located Near the Umbilical Fissure of the Left Hepatic Lobe: Angiographic Evaluation 2011 ·CardioVascular and Interventional Radiology ·Shiro Miyayama, Masashi Yamashiro, Yoshihiro Shibata, Masahiro Hashimoto, Miki Yoshida, (unknown), Fumihito Toshima, Osamu Matsui	2
19	Thrombolysis and thromboaspiration for acute thromboembolic occlusion in the upper extremity 2011 ·Japanese Journal of Radiology ·Shiro Miyayama, Masashi Yamashiro, Yoshihiro Shibata, Masahiro Hashimoto, Miki Yoshida, (unknown), Fumihito Toshima, Osamu Matsui	7
20	Arterial blood supply to the caudate lobe of the liver from the proximal branches of the right inferior phrenic artery in patients with recurrent hepatocellular carcinoma after chemoembolization 2011 ·Japanese Journal of Radiology ·Shiro Miyayama, Masashi Yamashiro, Yoshihiro Shibata, Masahiro Hashimoto, Miki Yoshida, (unknown), Fumihito Toshima, Osamu Matsui	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact